Page last updated: 2024-11-07

penicillamine and Urinary Lithiasis

penicillamine has been researched along with Urinary Lithiasis in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
"To describe the natural history and quality of life (QoL) in patients with cystine urolithiasis."7.81Natural history and quality of life in patients with cystine urolithiasis: a single centre study. ( Desai, D; Parr, JM; Winkle, D, 2015)
"To describe the natural history and quality of life (QoL) in patients with cystine urolithiasis."3.81Natural history and quality of life in patients with cystine urolithiasis: a single centre study. ( Desai, D; Parr, JM; Winkle, D, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parr, JM1
Desai, D1
Winkle, D1

Other Studies

1 other study available for penicillamine and Urinary Lithiasis

ArticleYear
Natural history and quality of life in patients with cystine urolithiasis: a single centre study.
    BJU international, 2015, Volume: 116 Suppl 3

    Topics: Adult; Aged; Australia; Chelating Agents; Cohort Studies; Cystine; Cystinuria; Female; Health Survey

2015